Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05218044 · ClinicalTrials.gov registry record · NA
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
A NA study of Ductal Carcinoma In Situ, sponsored by Glendale Adventist Medical Center d/b/a Adventist Health Glendale.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05218044 is a NA study of Ductal Carcinoma In Situ that is actively recruiting participants, run by Glendale Adventist Medical Center d/b/a Adventist Health Glendale. The registered enrollment target is 30 participants, below the 255-participant average among 15 other Ductal Carcinoma In Situ trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05218044, a NA study of Ductal Carcinoma In Situ, is actively recruiting participants, sponsored by Glendale Adventist Medical Center d/b/a Adventist Health Glendale.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Cryoablation or tumor freezing is a percutaneous, office-based procedure that is emerging as a minimally invasive, cost-effective alternative to surgery that is currently being evaluated in clinical trials for the management of for early-stage invasive breast cancer. The investigator will also evaluate the potential of cryoablation as a minimally invasive alternative to surgery for small areas of DCIS by examining its ability to achieve complete ablation of DCIS within the targeted cryoablation zone of necrosis.
Conditions Studied
Interventions
- PROCEDURE Cryoablation
Study Locations (1)
California
- Office of Dennis R. Holmes, M.D., F.A.C.S. - Glendale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05218044
The ClinicalTrials.gov registry entry for NCT05218044 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 15 other Ductal Carcinoma In Situ trials with a reported enrollment target (88% lower). The listed sponsor is Glendale Adventist Medical Center d/b/a Adventist Health Glendale, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ductal Carcinoma In Situ appearing as the primary indexed condition, and to 1 intervention - of which Cryoablation is the first listed.
NCT05218044 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05218044 about?
NCT05218044 is a clinical study titled "Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ". Cryoablation or tumor freezing is a percutaneous, office-based procedure that is emerging as a minimally invasive, cost-effective alternative to surgery that is currently being evaluated in clinical trials for the management of for early-stage invasive breast cancer. The investigator will also evalu...
What is the current status of trial NCT05218044?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-11-01. Estimated completion is 2026-11-01.
What conditions does trial NCT05218044 study?
This clinical trial studies the following conditions: Ductal Carcinoma In Situ.
What interventions are being tested in trial NCT05218044?
The interventions under investigation include: Cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT05218044?
This trial is sponsored by Glendale Adventist Medical Center d/b/a Adventist Health Glendale, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05218044 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ductal Carcinoma In Situ
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
RECRUITING · NA
-
Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
RECRUITING · NA
-
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS
ACTIVE NOT RECRUITING · NA
-
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
ACTIVE NOT RECRUITING · NA
-
Intraoperative Radiation Therapy (IORT) in DCIS
ACTIVE NOT RECRUITING · NA
-
Living Well After Breast Surgery
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.